Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > SYK Stryker Corp > Detailed Quotes

SYK Stryker Corp

Watchlist
282.480
+3.530+1.27%
Close  02/02 16:00 ET
279.510
-2.970-1.05%
Pre Mkt Price 02/03 09:09 ET
High
282.560
Open
276.440
Turnover
565.58M
Low
276.030
Pre Close
278.950
Volume
2.02M
Market Cap
106.90B
P/E(TTM)
43.93
52wk High
282.560
Shares
378.43M
P/E(Static)
54.22
52wk Low
187.616
Float Cap
94.90B
Bid/Ask %
0.00%
Historical High
282.560
Shs Float
335.97M
Volume Ratio
1.04
Historical Low
3.267
Dividend TTM
2.835
Div Yield TTM
2.835
P/B
6.49
Dividend LFY
1.00%
Div Yield LFY
1.00%
Turnover Ratio
0.60%
Amplitude
2.34%
Avg Price
279.930
Lot Size
1
Float Cap
94.90B
Bid/Ask %
0.00%
Historical High
282.560
Shs Float
335.97M
Volume Ratio
1.04
Historical Low
3.267
Dividend TTM
2.835
P/B
6.49
Dividend LFY
1.00%
Turnover Ratio
0.60%
Amplitude
2.34%
Avg Price
279.930
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Stryker Corp. operates as a medical technology company. It operates through the following segments: Orthopaedics & Spine and MedSurg & Neurotechnology. The Orthopaedics & Spine segment provides implants for use in total joint replacements, such as hip, knee, and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that are used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, patient & caregiver safety technologies, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques, products for brain and open skull based surgical procedures, orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.
CEO: Mr. Kevin A. Lobo
Market: NYSE
Listing Date: 05/01/1979
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist